Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BiVictriX Therapeutics PLC (GB:BVX)
LSE:BVX
RESEARCH TOOLSreports
BiVictriX Therapeutics PLC (BVX) Share Price & Analysis
0 Followers
BVX Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range9.00p - 16.00p
Previous Close11.5p
Volume20.00K
Average Volume (3M)21.25K
Market Cap
£9.49M
Enterprise Value6.50M
Total Cash (Recent Filing)£3.29M
Total Debt (Recent Filing)£295.00K
Price to Earnings (P/E)-3.6
Beta-0.11
Next Earnings
Sep 18, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume21,248
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BiVictriX Therapeutics PLC News
PremiumCompany Announcements
BiVictriX Eyes Market Edge with FDA Orphan Drug NodOptions Prices
Currently, No data available
---
Ownership Overview
3.47% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
96.53% Public Companies and
Individual Investors
BVX FAQ
What was BiVictriX Therapeutics PLC’s price range in the past 12 months?
BiVictriX Therapeutics PLC lowest share price was 9.00p and its highest was 16.00p in the past 12 months.
What is BiVictriX Therapeutics PLC’s market cap?
Currently, no data Available
When is BiVictriX Therapeutics PLC’s upcoming earnings report date?
BiVictriX Therapeutics PLC’s upcoming earnings report date is Sep 18, 2024 which is in 152 days.
How were BiVictriX Therapeutics PLC’s earnings last quarter?
Currently, no data Available
Is BiVictriX Therapeutics PLC overvalued?
According to Wall Street analysts BiVictriX Therapeutics PLC’s price is currently Overvalued.
Does BiVictriX Therapeutics PLC pay dividends?
BiVictriX Therapeutics PLC does not currently pay dividends.
What is BiVictriX Therapeutics PLC’s EPS estimate?
BiVictriX Therapeutics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BiVictriX Therapeutics PLC have?
BiVictriX Therapeutics PLC has 82,526,085 shares outstanding.
What happened to BiVictriX Therapeutics PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BiVictriX Therapeutics PLC?
Currently, no hedge funds are holding shares in GB:BVX
---
BiVictriX Therapeutics PLC Stock Smart Score
Company Description
BiVictriX Therapeutics PLC
BiVictriX Therapeutics PLC is a drug development company. It has developed its proprietary Bi-Cygni technology which utilises Antibody Drug Conjugates for the treatment of various cancers including Acute Myeloid Leukaemia.
---
Technical Analysis
Advanced Medical Solutions
―
Futura Medical
―
Genedrive
―
HUTCHMED (China) Limited
―
---